kabutan

KAINOS Laboratories,Inc.(4556) Summary

4556
TSE Standard
KAINOS Laboratories,Inc.
1,269
JPY
+8
(+0.63%)
Dec 5, 2:20 pm JST
8.19
USD
Dec 5, 12:20 am EST
Result
PTS
outside of trading hours
1,266
Dec 5, 2:20 pm JST
Summary Chart Historical News Financial Result
PER
8.9
PBR
0.77
Yield
2.52%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 10:01 am
1,269 JPY 8.17 USD
Previous Close Dec 4
1,261 JPY 8.11 USD
High Dec 5, 10:01 am
1,269 JPY 8.19 USD
Low Dec 5, 10:05 am
1,261 JPY 8.13 USD
Volume
1,600
Trading Value
2.00M JPY 0.01M USD
VWAP
1264.75 JPY 8.16 USD
Minimum Trading Value
126,900 JPY 819 USD
Market Cap
5.79B JPY 0.04B USD
Number of Trades
8
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly Low
1-Year Average
14
1-Year High Apr 28, 2025
198
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 55,800
Nov 21, 2025 0 54,900
Nov 14, 2025 0 56,200
Nov 7, 2025 0 56,400
Oct 31, 2025 0 55,400
Company Profile
KAINOS Laboratories, Inc. is a mid-tier clinical diagnostics company specializing in renal function and allergy tests, with a focus on biochemistry and immunoserology.
Sector
Pharmaceuticals
KAINOS Laboratories, Inc. primarily engages in the manufacture and sale of in vitro diagnostic reagents and medical devices for clinical testing. The company operates independently without subsidiaries or affiliates, maintaining a continuous and close business relationship with Asahi Kasei Pharma. In the field of clinical diagnostics, KAINOS's main products include those for renal function and blood transfusion tests. The company particularly excels in biochemical and immunoserological testing, demonstrating its strengths in these areas. By providing essential products for diagnosis and treatment decisions in medical settings, KAINOS contributes to improving the quality of healthcare.